NCT00168896View on ClinicalTrials.gov

A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage

PHASE2/PHASE3UnknownINTERVENTIONAL
Enrollment

286

Participants

Timeline

Start Date

October 31, 2001

Study Completion Date

December 31, 2006

Conditions
Small Cell Lung Cancer
Interventions
DRUG

Carboplatin plus Irinotecan vs Carboplatin plus Etoposide

Trial Locations (1)

12203

RECRUITING

Hematology & Oncology Charité CBF Berlin, Germany, Berlin

Sponsors
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

collaborator

Aventis Pharmaceuticals

INDUSTRY

lead

Charite University, Berlin, Germany

OTHER